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SUMMARY Erythrocytes from lithium treated patients were separated according to the time they had been circulating in the plasma. Choline transport and choline content were measured in the erythrocyte fractions separated according to age, in order to investigate the relationship between decreased choline transport and increased choline content seen in lithium treated patients. The most recently formed erythrocytes of normal subjects had the greatest choline content and the most active choline carrier. The erythrocytes of lithium treated patients had reduced choline carrier activity and increased choline content in all age bands. However the greatest accumulation of choline and least inhibited choline carrier activity was seen in the most recently formed cells. The alteration in phospholipid concentrations measured could not of themselves account for elevated erythrocyte choline levels seen in lithium treated patients. It is concluded that the increase in choline content levels in lithiated erythrocytes does not have a simple inverse relationship with the deficiency in choline transport. The inhibition of the choline carrier is caused by modification due to circulation in lithiated plasma rather than a lack of its synthesis in reticulocytes.
Lithium is widely used as prophylaxis for the manic phase of bipolar affective disorder and there have been many studies on its biochemical effects.' One of the more striking effects is the irreversible inhibition (80-95%) of choline transport in erythrocytes2 and the even more dramatic increase ( 10-20 fold) in their choline content. Table 2 ) ofthe erythrocytes. Values are means ±SEM of choline influx (nmols/min/celi x 10'2) and choline content (nmol/celi x 10') in the 5 erythrocyte age fractions.
*The exact relationship between erythrocyte age and density is uncertain. However, from studies on the distribution of 29Fe tagged human erythrocytes'3 and similar labelling studies on rabbit erythrocytes,14 the ages of the various age bands have been approximated. Values obtained with total unfractionated blood are: lithium treated patients, choline influx 1-1 x 10-12 nmol/min/cell (n = 4), choline content 6 x 10-8 nmol/cell (n = 9); controls, choline influx 5 x 10-12 nmols/min/cell (n = 4) choline content 0-45 x 10-' nmol/cell (n = 18). (0-32-0.64 mg/ml of phospholipid would need to be catabolised to provide the elevated choline levels seen in lithium treated patients). However the decrease in the choline-containing phospholipid concentrations (phosphatidylcholine and sphingomyelin) in young and old erythrocytes, from lithium-treated patients and controls is insufficient to account for the increased choline concentration seen in the erythrocytes of patients treated with lithium. Unless there is a mechanism for renewing choline-containing membrane phospholipids these are not the source of the raised choline.
The deficiency in choline transport may be a consequence of the circulation of erythrocytes in lithiated plasma or it may be that lithium prevents the synthesis or incorporation of the choline carrier into the developing erythrocyte. In order to investigate this the erythrocytes from patients who had only just commenced a course of lithium treatment were investigated. Figure 2 shows age-separated erythrocyte choline influx, in two patients treated with lithium for 1-2 weeks, with for comparison patients treated with lithium for greater than 6 months and controls. Erythrocytes of patients commencing 
Discussion
The alteration in choline metabolism and transport seen in the erythrocytes of patients treated with lithium, has previously been explained by an inhibition of the choline carrier system preventing the efflux of choline released from membrane phospholipids.45 However two types of data obtained in this study are inconsistent with this view. The decrease in erythrocyte phospholipid levels is not sufficient to account for the elevation of free choline. Assuming the average phospholipid concentration of erythrocytes is 3-75 Amoles/ml, a 30-50% decrease in choline containing phospholipid concentrations would be needed to account for the elevated choline levels. Secondly erythrocyte choline levels are lower in the older fractions of lithiated cells, which also have the lowest activity of the choline carrier. Exchange between erythrocyte and plasma pools of sphingomyelin and phosphatidylcholine has been well documented '6 '' and has been estimated to be 9 All the erythrocytes from patients who had been treated with lithium for at least six months showed deficits in choline transport. The most recently formed erythrocytes however, in patients treated with lithium for 1-2 weeks show a comparatively unaffected choline carrier system. We therefore conclude that it is the circulation of erythrocytes in lithiated plasma, rather than any effect on the synthesis of carrier or its insertion into the membrane.
Our study suggests some slow acting interaction between lithium and biological membranes such that the choline carrier is inactivated. Generally lithium prophylaxis develops 2 weeks after commencement of treatment. The time scale over which the majority of change in choline metabolism occurs would seem to parallel the development of the therapeutic effect. It would clearly be of a great interest to know whether or not the alteration in choline metabolism produced by lithium in erythrocytes is paralleled in the brain. Experiments have shown a decrease in choline influx into rat brain after lithium administration. '9 But given the interspecies variability of this effect2 an extrapolation of this kind without some knowledge of its molecular basis is not without risk. The changes in patients and animals during lithium treatment will need to be characterised more fully but when both sets of information are taken together it may be possible to formulate testable hypotheses concerning affective disorder, lithium therapy and choline metabolism and transport.
